Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
301130.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2,043 | CN¥2,253 | CN¥2,333 | CN¥4,607 |
| - Cash | CN¥191 | CN¥334 | CN¥203 | CN¥149 |
| + Debt | CN¥10 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥1,863 | CN¥1,919 | CN¥2,130 | CN¥4,458 |
| Revenue | CN¥256 | CN¥225 | CN¥255 | CN¥286 |
| % Growth | 13.7% | -11.7% | -10.6% | – |
| Gross Profit | CN¥196 | CN¥181 | CN¥209 | CN¥239 |
| % Margin | 76.5% | 80.3% | 81.6% | 83.7% |
| EBITDA | CN¥69 | CN¥77 | CN¥59 | CN¥78 |
| % Margin | 27% | 34.1% | 22.9% | 27.3% |
| Net Income | CN¥40 | CN¥51 | CN¥41 | CN¥52 |
| % Margin | 15.7% | 22.4% | 15.9% | 18.2% |
| EPS Diluted | 0.52 | 0.62 | 0.5 | 0.64 |
| % Growth | -16.1% | 24% | -21.9% | – |
| Operating Cash Flow | CN¥54 | CN¥54 | CN¥67 | CN¥59 |
| Capital Expenditures | -CN¥135 | -CN¥123 | -CN¥54 | -CN¥21 |
| Free Cash Flow | -CN¥81 | -CN¥69 | CN¥13 | CN¥38 |